Bruker | BRKR - Gross Profit On Sales


Bruker reported $379.8M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
ABB USD 3.44B 218M Mar/2026
Agilent USD 990M 44M Mar/2026
Ametek USD 830.74M 110.32M Mar/2026
Bio Techne USD 208.29M 17.01M Mar/2026
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Bruker USD 379.8M 69.4M Mar/2026
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Danaher USD 3.59B 375M Mar/2026
Fujikura JPY 73.38B 1.31B Jun/2025
Furukawa JPY 7.5B 280M Jun/2025
General Electric Aerospace USD 4.24B 439M Mar/2026
Hitachi JPY 944.64B 135.59B Mar/2026
Illumina USD 721M 38M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Mitsubishi Electric JPY 462.9B 44.34B Mar/2025
Mitsubishi Heavy Industries JPY 266.2B 9.82B Jun/2025
Myriad Genetics USD 146.8M 3M Dec/2025
Nikon Corporation JPY 67.21B 14.78B Jun/2025
Olympus JPY 192.76B 27.86B Mar/2026
Repligen USD 108.28M 4.45M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Smiths GBP 430M 16M Dec/2022
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 542M 15.42M Mar/2026